Showing 321 - 340 results of 16,716 for search '(( 50 μ decrease ) OR ( 50 ((((mg decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 0.54s Refine Results
  1. 321

    Fig 4 - by Dalia Zaafar (6693017)

    Published 2022
    Subjects:
  2. 322
  3. 323
  4. 324
  5. 325
  6. 326
  7. 327
  8. 328
  9. 329

    Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

    Published 2025
    “…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. A representative HPD <b>1466</b>, with a 50% effective concentration against HBV replication of 0.25 µM, decreased capsid and core protein accumulation by 50–90% in HepDES19 and HepG2.2.15 cells. …”
  10. 330

    Identification of a Novel Protein Phosphatase 2A Activator, PPA24, as a Potential Therapeutic for FOLFOX-Resistant Colorectal Cancer by Hannah Johnson (1342596)

    Published 2024
    “…<b>PPA24</b> (<b>19a</b>) was identified as the most cytotoxic compound with IC<sub>50</sub> values in the range of 2.36–6.75 μM in CRC and FOLFOX-resistant CRC cell lines. …”
  11. 331
  12. 332
  13. 333
  14. 334
  15. 335
  16. 336

    Antimicrobial activity of RP-1 peptide conjugate with ferrocene group by Natalia C. S. Costa (8626206)

    Published 2020
    “…In comparison with amphotericin B, a second-line drug approved for leishmaniasis treatment, (IC<sub>50</sub> = 0.63 μmol L<sup>-1</sup>), Fc-RP1 was more active and showed a 2.5-fold higher selectivity index. …”
  17. 337

    Gene clustering identifies up- and down-regulated groups that control development, pluripotency, and cell division. by Michael Shelton (382572)

    Published 2019
    “…<p>Pluripotent H9 hESCs were differentiated for 50 days as previously described [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0222946#pone.0222946.ref012" target="_blank">12</a>], beginning with high (7.5 μM or 10 μM) CHIR99021 concentrations. mRNA samples from the indicated time points were subjected to gene expression profiling. …”
  18. 338
  19. 339
  20. 340